Advertisement
Australia markets closed

  • ALL ORDS

    7,811.40
    -87.50 (-1.11%)
     

  • ASX 200

    7,561.10
    -81.00 (-1.06%)
     

  • AUD/USD

    0.6405
    -0.0021 (-0.32%)
     

  • OIL

    84.39
    +1.66 (+2.01%)
     

  • GOLD

    2,395.20
    -2.80 (-0.12%)
     

  • Bitcoin AUD

    96,872.25
    +1,316.23 (+1.38%)
     

  • CMC Crypto 200

    1,283.18
    -29.45 (-2.24%)
     

  • AUD/EUR

    0.6019
    -0.0011 (-0.19%)
     

  • AUD/NZD

    1.0884
    +0.0009 (+0.08%)
     

  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     

  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     

  • FTSE

    7,877.05
    +29.06 (+0.37%)
     

  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     

  • DAX

    17,837.40
    +67.38 (+0.38%)
     

  • Hang Seng

    16,138.74
    -247.13 (-1.51%)
     

  • NIKKEI 225

    37,135.60
    -944.10 (-2.48%)
     

Miromatrix Announces Participation in the 20th Annual Craig-Hallum Institutional Investor Conference

Miromatrix Medical Inc.
·1-min read
Miromatrix Medical Inc.
Miromatrix Medical Inc.

EDEN PRAIRIE, Minn., May 30, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, announced that members of the management team will participate in the upcoming 20th Annual Craig-Hallum Institutional Investor Conference on May 31st, 2023. Due to the format of this event, no webcast will be available.

About Miromatrix
Miromatrix Medical Inc. is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients' lives. The Company has developed a proprietary perfusion technology platform for bioengineering organs that it believes will efficiently scale to address the shortage of available human organs. The Company's initial development focus is on human livers and kidneys. For more information, visit miromatrix.com.

Investor Contact
Greg Chodaczek
347-620-7010
ir@miromatrix.com

Media Contact:
press@miromatrix.com